{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:59:24Z","timestamp":1792191564964,"version":"4.4.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","onlinecjc.ca","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.cjca.2022.02.029","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T06:46:29Z","timestamp":1651905989000},"page":"560-587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease"],"prefix":"10.1016","volume":"38","author":[{"given":"Beth L.","family":"Abramson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Al-Omran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia S.","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaina","family":"Albalawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"de Mestral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randolph","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad A.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor F.","family":"Huckell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Jetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Kaplovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Karlstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Kayssi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.B John","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"McClure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Sean","family":"McMurtry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir","family":"Nagpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Nault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Petrasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Rannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek J.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Roussin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Saw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajenny","family":"Srivaratharajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Szalay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Virani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2022.02.029_bib2","first-page":"306","article-title":"Diagnosis and treatment of peripheral arterial disease","volume":"88","author":"Hennion","year":"2013","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.cjca.2022.02.029_bib3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/0895-4356(92)90150-L","article-title":"The Edinburgh Claudication Questionnaire: an improved version of the WHO\/Rose questionnaire for use in epidemiological surveys","volume":"45","author":"Lend","year":"1992","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/0003319719896477","article-title":"A\u00a0targeted literature review of the disease burden in patients with symptomatic peripheral artery disease","volume":"71","author":"Bauersachs","year":"2020","journal-title":"Angiology"},{"key":"10.1016\/j.cjca.2022.02.029_bib5","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1161\/CIR.0b013e318276fbcb","article-title":"Measurement and interpretation of the Ankle-Brachial Index: a scientific statement from the American Heart Association","volume":"126","author":"Aboyans","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2022.02.029_bib6","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/jama.295.5.536","article-title":"Does the clinical examination predict lower extremity peripheral arterial disease?","volume":"295","author":"Khan","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2022.02.029_bib7","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/1358863X16645854","article-title":"A\u00a0systematic review of the sensitivity and specificity of the toe-brachial index for detecting peripheral artery disease","volume":"21","author":"Tehan","year":"2016","journal-title":"Vasc Med"},{"key":"10.1016\/j.cjca.2022.02.029_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.atherosclerosis.2020.09.026","article-title":"The accuracy of toe brachial index and ankle brachial index in the diagnosis of lower limb peripheral arterial disease: a systematic review and meta-analysis","volume":"315","author":"Herraiz-Adillo","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2022.02.029_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14379","article-title":"Estimating the diagnostic accuracy of the ankle\u2013brachial pressure index for detecting peripheral arterial disease in people with diabetes: a systematic review and meta-analysis","volume":"38","author":"Chuter","year":"2021","journal-title":"Diabet Med"},{"key":"10.1016\/j.cjca.2022.02.029_bib10","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jvs.2020.11.030","article-title":"A\u00a0systematic review and meta-analysis of the diagnostic accuracy of point-of-care tests used to establish the presence of peripheral arterial disease in people with diabetes","volume":"73","author":"Normahani","year":"2021","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib11","first-page":"1","article-title":"Epidemiology of peripheral arterial disease in women","volume":"13","author":"Higgins","year":"2003","journal-title":"J\u00a0Epidemiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jvs.2011.07.074","article-title":"Gender is an independent risk factor for distribution pattern and lesion morphology in chronic critical limb ischemia","volume":"55","author":"Ortmann","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib13","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jvs.2007.02.004","article-title":"A\u00a0population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences","volume":"45","author":"Sigvant","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"issue":"3suppl","key":"10.1016\/j.cjca.2022.02.029_bib14","doi-asserted-by":"crossref","first-page":"42S","DOI":"10.1016\/j.jvs.2014.12.008","article-title":"A\u00a0systematic review for the screening for peripheral arterial disease in asymptomatic patients","volume":"61","author":"Alahdab","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/jama.2018.4250","article-title":"Screening for peripheral artery disease using the Ankle-Brachial Index updated evidence report and systematic review for the US preventive services task force","volume":"320","author":"Guirguis-Blake","year":"2018","journal-title":"JAMA"},{"issue":"3 suppl","key":"10.1016\/j.cjca.2022.02.029_bib16","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijcard.2017.11.081","article-title":"Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: the randomized AMERICA study","volume":"254","author":"Collet","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib19","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1016\/j.jacc.2019.02.079","article-title":"Rivaroxaban plus aspirin versus aspirin in relation to vascular risk in the COMPASS Trial","volume":"73","author":"Anand","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib20","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk)","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2022.02.029_bib21","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.jacc.2016.03.524","article-title":"Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease","volume":"67","author":"Bonaca","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib22","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1016\/j.jacc.2019.04.046","article-title":"Association of multiple enrichment criteria with ischemic and bleeding risks among COMPASS-eligible patients","volume":"73","author":"Darmon","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2021.05.049","article-title":"Cost-effectiveness analysis of Ankle-Brachial Index screening in patients with coronary artery disease to optimize medical management","volume":"74","author":"Minami","year":"2021","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.5239","article-title":"Polyvascular disease and risk of major adverse cardiovascular events in peripheral artery disease: a secondary analysis of the EUCLID trial","volume":"1","author":"Gutierrez","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cjca.2022.02.029_bib25","first-page":"CD013229","article-title":"Behavioural interventions for smoking cessation: an overview and network meta-analysis","volume":"1","author":"Hartmann-Boyce","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cjca.2022.02.029_bib26","first-page":"CD000031","article-title":"Antidepressants for smoking cessation","volume":"4","author":"Howes","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"suppl 1","key":"10.1016\/j.cjca.2022.02.029_bib27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/dmrr.2703","article-title":"Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: a systematic review","volume":"32","author":"Brownrigg","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.cjca.2022.02.029_bib28","first-page":"CD006103","article-title":"Nicotine receptor partial agonists for smoking cessation","volume":"2016","author":"Cahill","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cjca.2022.02.029_bib29","first-page":"CD010216","article-title":"Electronic cigarettes for smoking cessation","volume":"4","author":"Hartmann-Boyce","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cjca.2022.02.029_bib30","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jvs.2021.07.248","article-title":"A\u00a0meta-analysis of randomised controlled trials evaluating the efficacy of smoking cessation interventions in people with peripheral artery disease","volume":"75","author":"Thanigaimani","year":"2022","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib31","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jacc.2010.07.031","article-title":"Effectiveness of a smoking cessation program for peripheral artery disease patients: a randomized controlled trial","volume":"56","author":"Hennrikus","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib32","first-page":"CD001292","article-title":"Individual behavioural counselling for smoking cessation","volume":"3","author":"Lancaster","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cjca.2022.02.029_bib33","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2337\/diacare.24.8.1433","article-title":"Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome","volume":"24","author":"Jude","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cjca.2022.02.029_bib34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF02369357","article-title":"Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn Study","volume":"38","author":"Beks","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.cjca.2022.02.029_bib35","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/01.CIR.0000112642.63927.54","article-title":"Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study","volume":"109","author":"Resnick","year":"2004","journal-title":"Circulation"},{"issue":"suppl 1","key":"10.1016\/j.cjca.2022.02.029_bib36","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1016\/j.jcjd.2017.10.024","article-title":"Cardiovascular protection in people with diabetes","volume":"42","author":"Stone","year":"2018","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.cjca.2022.02.029_bib37","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.amjmed.2016.10.016","article-title":"Dipeptidyl peptidase-4 inhibitors, peripheral arterial disease, and lower extremity amputation risk in diabetic patients","volume":"130","author":"Chang","year":"2017","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.cjca.2022.02.029_bib38","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s00125-021-05497-1","article-title":"Major adverse cardiovascular and limb events in patients with diabetes treated with GLP-1 receptor agonists vs DPP-4 inhibitors","volume":"64","author":"Lin","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.cjca.2022.02.029_bib39","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/CIRCULATIONAHA.119.044775","article-title":"Dapagliflozin and cardiac, kidney, and limb outcomes in patients with and without peripheral artery disease in DECLARE-TIMI 58","volume":"142","author":"Bonaca","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2022.02.029_bib40","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.diabres.2019.05.028","article-title":"Peripheral artery disease and amputations with sodium-glucose co-transporter-2 (SGLT-2) inhibitors: a meta-analysis of randomized controlled trials","volume":"153","author":"Dicembrini","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.cjca.2022.02.029_bib41","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1111\/dom.14159","article-title":"Sodium-glucose co-transporter-2 inhibitors and major adverse limb events: a trial-level meta-analysis including 51 713 individuals","volume":"22","author":"Huang","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.cjca.2022.02.029_bib42","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.cjca.2021.03.016","article-title":"2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib43","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0735-1097(01)01827-7","article-title":"Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects","volume":"39","author":"Verdecchia","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib44","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cjca.2020.02.086","article-title":"Hypertension Canada\u2019s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children","volume":"36","author":"Rabi","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib45","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jama.282.6.539","article-title":"Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension","volume":"282","author":"Staessen","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2022.02.029_bib46","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.kint.2018.08.021","article-title":"Minimally sufficient numbers of measurements for validation of 24-hour blood pressure monitoring in chronic kidney disease","volume":"94","author":"Agarwal","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2022.02.029_bib47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/174182670200900208","article-title":"Value of home blood pressures as predictor of target organ damage in mild arterial hypertension","volume":"9","author":"Mul\u00e8","year":"2002","journal-title":"Eur J Cardiovasc Prev Rehab"},{"key":"10.1016\/j.cjca.2022.02.029_bib48","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.HYP.35.3.844","article-title":"Prognostic value of ambulatory blood pressure: current evidence and clinical implications","volume":"35","author":"Verdecchia","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2022.02.029_bib49","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0randomized trial of intensive versus standard blood-pressure control","volume":"373","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.02.029_bib50","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/HYPERTENSIONAHA.109.142240","article-title":"Outcomes among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the international VErapamil-SR\/ trandolapril study","volume":"55","author":"Bavry","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2022.02.029_bib51","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jacc.2005.09.074","article-title":"Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease","volume":"47","author":"Feringa","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib52","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1093\/ehjcvp\/pvaa102","article-title":"Intensive blood pressure control appears to be effective and safe in patients with peripheral artery disease: the Systolic Blood Pressure Intervention Trial","volume":"7","author":"Frary","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.cjca.2022.02.029_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jash.2018.06.010","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary","volume":"12","author":"Whelton","year":"2018","journal-title":"J\u00a0Am Soc Hypertens"},{"key":"10.1016\/j.cjca.2022.02.029_bib54","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2022.02.029_bib55","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJMoa2028220","article-title":"Polypill with or without aspirin in persons without cardiovascular disease","volume":"384","author":"Yusuf","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.02.029_bib56","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1358863X15574321","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia","volume":"20","author":"Armstrong","year":"2015","journal-title":"Vasc Med"},{"key":"10.1016\/j.cjca.2022.02.029_bib57","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1815359","article-title":"Polypill for cardiovascular disease prevention in an underserved population","volume":"381","author":"Mu\u00f1oz","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.02.029_bib59","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejvs.2009.02.019","article-title":"Beta blockers for peripheral arterial disease","volume":"38","author":"Paravastu","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib60","doi-asserted-by":"crossref","first-page":"481","DOI":"10.5551\/jat.27359","article-title":"Beta-blocker treatment does not worsen critical limb ischemia in patients receiving endovascular therapy","volume":"22","author":"Soga","year":"2014","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.cjca.2022.02.029_bib61","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A\u00a0randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2022.02.029_bib62","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2022.02.029_bib63","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/CIRCULATIONAHA.121.055146","article-title":"Reduction in acute limb ischemia with rivaroxaban versus placebo in peripheral artery disease after lower extremity revascularization: insights from VOYAGER PAD","volume":"144","author":"Hess","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2022.02.029_bib64","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2022.02.029_bib65","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.cjca.2020.09.001","article-title":"The 2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation","volume":"36","author":"Andrade","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib67","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.cjca.2018.08.026","article-title":"2018 Focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation","volume":"34","author":"Andrade","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib68","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJMoa1904143","article-title":"Antithrombotic therapy for atrial fibrillation with stable coronary disease","volume":"381","author":"Yasuda","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.02.029_bib69","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Baigent","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2022.02.029_bib70","first-page":"CD002071","article-title":"Antiplatelet and anticoagulant drugs for prevention of restenosis\/reocclusion following peripheral endovascular treatment","volume":"2012","author":"Robertson","year":"2012","journal-title":"Cochrane Database Syst Rev Published online"},{"key":"10.1016\/j.cjca.2022.02.029_bib71","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2022.02.029_bib72","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1148\/radiology.193.2.7972781","article-title":"Low-dose aspirin combined with dipyridamole versus anticoagulants after femoropopliteal percutaneous transluminal angioplasty","volume":"193","author":"Do","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.cjca.2022.02.029_bib73","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/01.CIR.83.1.141","article-title":"Nd:YAG laser with sapphire tip combined with balloon angioplasty in peripheral arterial occlusions: long-term results","volume":"83","author":"Pilger","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2022.02.029_bib74","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation","volume":"380","author":"Lopes","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.02.029_bib75","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"Cannon","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.02.029_bib76","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.02.029_bib77","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cjca.2017.12.012","article-title":"2018 Canadian Cardiovascular Society\/Canadian Association of Interventional Cardiology focused update of the guidelines for the use of antiplatelet therapy","volume":"34","author":"Mehta","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib78","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/1526602818760488","article-title":"Edoxaban plus aspirin vs dual antiplatelet therapy in endovascular treatment of patients with peripheral artery disease: results of the ePAD trial","volume":"25","author":"Moll","year":"2018","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.cjca.2022.02.029_bib79","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.02.029_bib80","first-page":"CD00053","article-title":"Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery","volume":"2015","author":"Bedenis","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cjca.2022.02.029_bib81","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jvs.2010.04.027","article-title":"Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial","volume":"52","author":"Belch","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib82","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0140-6736(99)07199-8","article-title":"Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral anticoagulants or Aspirin study): a randomised trial","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2022.02.029_bib83","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0741-5214(98)70130-2","article-title":"Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure","volume":"28","author":"Sarac","year":"1998","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib84","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1067\/mva.2002.121847","article-title":"Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients peripheral arterial bypass procedures: a prospective randomized study","volume":"35","author":"Johnson","year":"2002","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib85","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jvs.2012.01.004","article-title":"Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients","volume":"56","author":"Monaco","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib86","first-page":"2219","article-title":"Rivaroxaban and aspirin in peripheral artery disease lower extremity revascularization: impact of concomitant clopidogrel on efficacy and safety","volume":"142","author":"Hiatt","year":"2020"},{"key":"10.1016\/j.cjca.2022.02.029_bib87","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cjca.2020.06.008","article-title":"A\u00a0national Canadian survey of antithrombotic therapy after urgent and emergent limb revascularization","volume":"37","author":"McClure","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib88","first-page":"e686","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2022.02.029_bib89","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2022.02.029_bib90","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cjca.2016.09.008","article-title":"Canadian Cardiovascular Society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery","volume":"33","author":"Duceppe","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib91","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jvs.2010.03.031","article-title":"The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients","volume":"52","author":"Bertges","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2016.04.045","article-title":"The Vascular Quality Initiative Cardiac Risk Index for prediction of myocardial infarction after vascular surgery","volume":"64","author":"Bertges","year":"2016","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib93","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/SLA.0000000000000767","article-title":"The impact of functional dependency on outcomes after complex general and vascular surgery","volume":"261","author":"Scarborough","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib94","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jss.2015.10.026","article-title":"Gender and frailty predict poor outcomes in infrainguinal vascular surgery","volume":"201","author":"Brahmbhatt","year":"2016","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.cjca.2022.02.029_bib95","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ejvs.2019.04.031","article-title":"The effect of frailty on outcome after vascular surgery","volume":"58","author":"Visser","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib96","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/SLA.0000000000003642","article-title":"Frailty factors and outcomes in vascular surgery patients: a systematic review and meta-analysis","volume":"272","author":"Houghton","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib97","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jvs.2018.07.050","article-title":"Association of frailty index with perioperative mortality and in-hospital morbidity after elective lower extremity bypass","volume":"69","author":"Eslami","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib98","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archinte.165.8.898","article-title":"Optimizing the prediction of perioperative mortality in vascular surgery by using a customized probability model","volume":"165","author":"Kertai","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2022.02.029_bib99","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1053\/j.jvca.2017.08.036","article-title":"Physiological and Operative Severity Score for the enumeration of Mortality and Morbidity (POSSUM) system for outcome prediction in elderly patients undergoing major vascular surgery","volume":"32","author":"Teixeira","year":"2018","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.cjca.2022.02.029_bib100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijsu.2019.12.010","article-title":"Incidence, predictors and validation of risk scores to predict postoperative mortality after noncardiac vascular surgery, a prospective cohort study","volume":"73","author":"Reis","year":"2020","journal-title":"Int J Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib101","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jacc.2013.08.1630","volume":"63","author":"Rodseth","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"suppl S","key":"10.1016\/j.cjca.2022.02.029_bib102","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib103","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1067\/mva.2001.119749","article-title":"Natural history of claudication: long-term serial follow-up study of 1244 claudicants","volume":"34","author":"Aquino","year":"2001","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib104","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/bmj.293.6555.1137","article-title":"Fate in intermittent claudication: outcome and risk factors","volume":"293","author":"Jelnes","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.cjca.2022.02.029_bib105","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/jamasurg.2016.0415","article-title":"Efficacy of a guideline-recommended risk-reduction program to improve cardiovascular and limb outcomes in patients with peripheral arterial disease","volume":"151","author":"Hussain","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib106","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMcp1507631","article-title":"Peripheral artery disease","volume":"374","author":"Kullo","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.02.029_bib107","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.jacc.2016.04.071","article-title":"Critical limb ischemia: an expert statement","volume":"68","author":"Shishehbor","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib108","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jamasurg.2016.2018","article-title":"The current state of critical limb ischemia: a systematic review","volume":"151","author":"Farber","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib109","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.jacc.2018.03.483","article-title":"Antithrombotic therapy for peripheral artery disease: recent advances","volume":"71","author":"Hussain","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib110","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jacc.2015.12.049","article-title":"Peripheral artery disease: evolving role of exercise, medical therapy, and endovascular options","volume":"67","author":"Olin","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib111","article-title":"The natural history of untreated severe or critical limb ischemia","volume":"62","author":"Abu Dabrh","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"issue":"suppl 1","key":"10.1016\/j.cjca.2022.02.029_bib112","doi-asserted-by":"crossref","first-page":"e3279","DOI":"10.1002\/dmrr.3279","article-title":"Effectiveness of revascularisation of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review","volume":"36","author":"Forsythe","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.cjca.2022.02.029_bib113","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1056\/NEJMcp1006054","article-title":"Clinical practice. Acute limb ischemia","volume":"366","author":"Creager","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.02.029_bib114","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2022.02.029_bib115","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jvs.2012.07.038","article-title":"A\u00a0meta-analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease","volume":"57","author":"Antoniou","year":"2013","journal-title":"J\u00a0Vasc Surg"},{"issue":"5 suppl","key":"10.1016\/j.cjca.2022.02.029_bib116","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jvs.2010.01.073","article-title":"Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy","volume":"51","author":"Bradbury","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib117","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib118","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1067\/mva.2001.113486","article-title":"Percutaneous transluminal angioplasty of the femoropopliteal arteries in limbs with chronic critical lower limb ischemia","volume":"34","author":"L\u00f6fberg","year":"2001","journal-title":"J\u00a0Vasc Surg"},{"issue":"2 suppl","key":"10.1016\/j.cjca.2022.02.029_bib119","first-page":"I70","article-title":"Femoropopliteal angioplasty. Factors influencing long-term success","volume":"83","author":"Capek","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2022.02.029_bib120","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S1051-0443(07)61570-X","article-title":"Predictors of long-term patency after femoropopliteal angioplasty: results from the STAR registry","volume":"12","author":"Clark","year":"2001","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib121","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0741-5214(97)70053-3","article-title":"Results of aortic bifurcation grafts for aortoiliac occlusive disease: a meta-analysis","volume":"26","author":"de Vries","year":"1997","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib122","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jvs.2010.04.080","article-title":"A\u00a0systematic review of endovascular treatment of extensive aortoiliac occlusive disease","volume":"52","author":"Jongkind","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib123","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jvs.2020.10.026","article-title":"Systematic review and meta-analysis of endovascular versus open repair for common femoral artery atherosclerosis treatment","volume":"73","author":"Boufi","year":"2021","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib124","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2004.11.026","article-title":"Prevalence and clinical impact of stent fractures after femoropopliteal stenting","volume":"45","author":"Scheinert","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib125","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa051303","article-title":"Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery","volume":"354","author":"Schillinger","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.02.029_bib126","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468","article-title":"Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial","volume":"3","author":"Laird","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2022.02.029_bib127","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.avsg.2019.11.002","article-title":"Long-term patency and clinical outcomes of nitinol stenting for femoropopliteal atherosclerotic disease","volume":"66","author":"Abdoli","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib128","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jvir.2012.10.004","volume":"24","author":"Saxon","year":"2013","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib129","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jvs.2013.01.050","article-title":"Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease","volume":"58","author":"Geraghty","year":"2013","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib130","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jcin.2021.01.026","article-title":"2-Year outcomes of the Eluvia drug-eluting stent for the treatment of complex femoropopliteal lesions","volume":"14","author":"Stavroulakis","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2022.02.029_bib131","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","article-title":"Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial","volume":"11","author":"Schneider","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2022.02.029_bib132","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.02.029_bib133","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.02.029_bib134","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jvs.2019.01.080","article-title":"Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease","volume":"70","author":"Caradu","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib135","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ahj.2019.12.012","article-title":"Paclitaxel-related balloons and stents for the treatment of peripheral artery disease: insights from the Food and Drug Administration 2019 Circulatory System Devices Panel Meeting on late mortality: paclitaxel devices in PAD treatment","volume":"222","author":"Dan","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2022.02.029_bib136","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2022.02.029_bib137","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4174\/astr.2021.101.1.20","article-title":"Association of mortality with drug-coated devices in femoropopliteal artery based on the nationwide data","volume":"101","author":"Choi","year":"2021","journal-title":"Ann Surg Treat Res"},{"key":"10.1016\/j.cjca.2022.02.029_bib138","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.jacc.2019.01.013","article-title":"Mortality not correlated with paclitaxel exposure: an independent patient-level meta-analysis of a drug-coated balloon","volume":"73","author":"Schneider","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.02.029_bib139","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1526602819895996","article-title":"Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions: a network meta-analysis of randomized controlled trials","volume":"27","author":"Zhou","year":"2020","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.cjca.2022.02.029_bib140","first-page":"231","article-title":"The value of subintimal angioplasty in the management of critical lower extremity ischemia: failure is not always associated with a rethreatened limb","volume":"45","author":"Lipsitz","year":"2004","journal-title":"J\u00a0Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.cjca.2022.02.029_bib141","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ccd.22658","article-title":"Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease","volume":"76","author":"Schmidt","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2022.02.029_bib142","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jvs.2019.12.035","article-title":"Meta-analysis of direct surgical versus endovascular revascularization for aortoiliac occlusive disease","volume":"72","author":"Premaratne","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib143","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0002-9610(91)91104-Q","article-title":"Femoro-femoral or ilio-femoral bypass for unilateral inflow reconstruction?","volume":"161","author":"Perler","year":"1991","journal-title":"Am J Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib144","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jvs.2010.06.018","article-title":"Development of femoro-femoral and axillo-femoral bypass procedures","volume":"53","author":"Blaisdell","year":"2011","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib145","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jvs.2018.01.061","article-title":"Improved patency after axillofemoral bypass for aortoiliac occlusive disease","volume":"68","author":"Samson","year":"2018","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib146","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.amjsurg.2016.02.003","article-title":"The role of axillofemoral bypass in current vascular surgery practice","volume":"211","author":"Nguyen","year":"2016","journal-title":"Am J Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib147","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/j.ejvs.2019.04.013","article-title":"A\u00a0systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia","volume":"58","author":"Almasri","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib148","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jvs.2019.11.041","article-title":"Rapid increase in hybrid surgery for the treatment of peripheral artery disease in the Vascular Quality Initiative database","volume":"72","author":"Fereydooni","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2022.02.029_bib149","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","article-title":"Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial","volume":"366","author":"Bradbury","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2022.02.029_bib150","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003219","article-title":"Design and rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) Trial","volume":"5","author":"Menard","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2022.02.029_bib151","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13063-015-1114-2","article-title":"Bypass versus Angio plasty in Severe Ischaemia of the Leg - 2 (BASIL-2) trial: study protocol for a randomised controlled trial","volume":"17","author":"Popplewell","year":"2016","journal-title":"Trials"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X22001568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X22001568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T13:34:55Z","timestamp":1725716095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X22001568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":147,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0828282X22001568"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2022.02.029","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2022.02.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}